IDiyas

For the Inventor, By the Inventor

Durham, CT, United States of America

Michael A Walker

USPTO Granted Patents = 24

 

Average Co-Inventor Count = 5.9

ph-index = 8

Forward Citations = 136(Granted Patents)


Location History:

  • Durham, CT (US) (1998 - 2014)
  • Durham, CO (US) (2016)
  • Wallingford, CT (US) (2018 - 2019)

Company Filing History:

goldMedal22 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal2 out of 42 
 
Viiv Healthcare UK (no.5) Limited
 patents

Years Active: 1998-2019

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 10407410 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-09-10),
2. 10125148 - Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication (2018-11-13),
3. 9273067 - Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication (2016-03-01),
4. 8906929 - Inhibitors of human immunodeficiency virus replication (2014-12-09),
5. 8846659 - HIV integrase inhibitors (2014-09-30),
6. 8835411 - HIV integrase inhibitors (2014-09-16),
7. 8629276 - Inhibitors of human immunodeficiency virus replication (2014-01-14),
8. 8383639 - HIV integrase inhibitors (2013-02-26),
9. 8129398 - HIV integrase inhibitors (2012-03-06),
10. 8039458 - HIV integrase inhibitors (2011-10-18),
11. 7902182 - HIV integrase inhibitors (2011-03-08),
12. 7893055 - HIV integrase inhibitors (2011-02-22),
13. 7511037 - N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor (2009-03-31),
14. 7192948 - Bicyclic heterocycles as HIV integrase inhibitors (2007-03-20),
15. 7176196 - Bicyclic heterocycles as HIV integrase inhibitors (2007-02-13),

Title: The Innovation Journey of Michael A Walker from Durham, CT

Introduction:

Michael A Walker, a prolific inventor hailing from Durham, CT, has made significant contributions to the field of pharmaceuticals with a total of 24 patents under his belt.

Latest Patents:

1. Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication: Walker's innovative compounds and methods have shown promise in inhibiting HIV integrase, offering hope in the treatment of HIV and AIDS.

2. Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication: His work on novel inhibitors for HIV paves the way for more effective pharmaceutical compositions in treating HIV infections.

Career Highlights:

Walker has worked with renowned companies such as Bristol-Myers Squibb Company and ViiV Healthcare UK (No. 5) Limited, where his expertise and inventive spirit have flourished.

Collaborations:

During his career, Walker has collaborated with esteemed professionals in the field, including B Narasimhulu Naidu and Margaret E Sorenson, further enriching the innovation landscape in which he thrives.

Conclusion:

Michael A Walker's dedication to innovation and his groundbreaking patents in the realm of HIV treatment underscore his commitment to making a difference in the world of pharmaceuticals. His work stands as a testament to the power of innovation in shaping a better future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…